(MedPage Today) — When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to treatment for some patients, with its high end durable response rates, and lengthy survival outcomes…
Source link : https://www.medpagetoday.com/spotlight/follicular-lymphoma/115576
Author :
Publish date : 2025-05-14 16:16:00
Copyright for syndicated content belongs to the linked Source.
